JSW Steel (JSTL) closed Q4FY25 with a mixed performance. The headline numbers showed growth, but realizations didn’t quite hit the mark. Nonetheless, the company remains laser-focused on capacity expansion and margin enhancement initiatives.

Max Financial wrapped up Q4FY25 with a calm, confident performance. The headline numbers may not scream "breakout," but underneath lies steady growth in value of new business, expanding margins, and bullish forward guidance from management.

Metro Brands delivered a decent Q4FY25, with revenue growth and margin improvement continuing from the previous quarter. However, elevated valuations and some execution challenges have prompted a more cautious view.

Blue Jet Healthcare has delivered a strong Q4 finish to cap off FY25. With robust traction in pharma intermediates (PI) and APIs, the company posted results that beat expectations comfortably. Yes, contrast media intermediates did slow things down a little, but overall, the growth engine looks well-fuelled for the long haul.

After a flat opening, Nifty witnessed buying momentum that lifted it up to 24,900 in the first half. It then remained range-bound between 24,800–24,900 and finally settled with a gain of 0.99%.

United Spirits (UNSP) wrapped up Q4FY25 on a steady note. Backed by robust value and volume growth, strategic tailwinds, and regulatory support, the company is setting the stage for sustained earnings expansion—even as it faces a few near-term consumption challenges.

On the backdrop of weak global sentiment, our market corrected sharply. The Nifty ends 204 points lower, while the Sensex was down by 645 points. Among sectors, Capital Market and FMCG indices corrected the most, shedding nearly 1.5%, whereas despite the weak sentiment, the Defense index outperformed, rallied 2.10%.

The wait will be over on May 26 when the initial public offering (IPO) of Schloss Bangalore Limited, owner and operator of The Leela luxury hotel chain, will open for public subscription. This is one of the largest IPOs in India's hospitality space in many years, thus generating a lot of interest from institutional and retail investors.

India’s IPO market in 2025 has seen 90 companies filing draft papers with SEBI between January and May, with 28 filings in January, 15 in February, 11 in March, 24 in April, and 12 in May.

Colgate-Palmolive (India) Ltd. (CLGT) reported a 1.8% revenue decline in Q4FY25, which missed our moderated estimate. This triggered a 2–3% cut in forward estimates and a revision of fair value to ₹2,535.